Thomas DeLauer
Episode overview

This Scientist Warns Against 16:8 Fasting (and how to fast properly)

Thomas DeLauer · 53m · 1 Egleze moment
This Scientist Warns Against 16:8 Fasting (and how to fast properly) ▶

What happened in this episode?

Thomas DeLauer interviews nutrition researcher Joel Greene about potential downsides of routine intermittent fasting—particularly daily 16:8—and how fasting might be made more “nature-aligned”. Greene argues that many biological effects sit on a U-shaped “Goldilocks” curve, where an intervention can be beneficial at one dose and harmful at another, and applies this to the gut bacterium Akkermansia muciniphila, which can feed on dietary substrates but also on the gut mucus layer.

Greene claims that prolonged fasting or very low-fibre eating can leave Akkermansia with fewer dietary substrates and may encourage erosion of the gut mucosal layer over time. He cites what he describes as a 2026 Swedish study of about 4,200 participants linking elevated Akkermansia, when combined with low-fibre diets, to higher likelihood of type 2 diabetes. He also alleges newer evidence that antibiotics may leave behind mutated Akkermansia strains that become overrepresented during recovery.

A recurring theme is Greene’s criticism of “daily” supplement-style thinking applied to microbiome products; he says diet diversity and intermittent exposure, rather than constant dosing, better fits human biology. In a personal account, Greene says years of fasting have left him susceptible to hyperphagia, making 24-hour fasts difficult, and he outlines a protocol he says can help curb it involving an early large meal, vitamin D, and fermentable fibre. The episode also includes a brief promotion by DeLauer for LMNT electrolyte drinks.

What are the key points?

Who is speaking?

Named speakers identified in Egleze's source-linked moments from this episode.

Which topics are covered?

How is this page sourced?

Programme
Thomas DeLauer
Duration
53m
Original episode
Open the original source ↗

Egleze verifies the speaker, source and timestamp for each linked moment. Unless a moment is explicitly marked independently verified, statements remain attributed claims by the named speaker rather than established facts.

Watch original episode More from Thomas DeLauer

1 moments from this episode

Source-linked · editorially selected
01
Health, Longevity & Biohacking

Guest Joel Green claims “new evidence” suggests post-antibiotic Akkermansia mutations can be detrimental

Joel Green · at 33:45 · Attributed speaker claim
So there's new evidence that um post probiotic, excuse me, post antibiotic, there are mutations in acromancia that essentially are overexpressed. Okay? So you go on a probiotic, you wipe out your microbiome, some bacteria survive. The one the acromancia that does survive, they tend to get mutations. Those mutations are detrimental.

Guest Joel Green claims there is “new evidence” that after a course of antibiotics, surviving Akkermansia may acquire mutations and become overrepresented as the microbiome repopulates, which he alleges can be harmful. He argues this could, in some cases, support a short, targeted approach to “reseeding” the microbiome rather than focusing on daily feeding of the existing population.